In summary, our data suggest that not only systemic inflammation but also vascular inflammation may play a role in the pathogenesis of CVD and of accelerated CVD in RA, with IL‐33 and related cytokines being potentially important players. Here, IL33 is linked to rheumatoid arthritis.